City Therapeutics Inc. (CTY) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Dec 3Dec 8Dec 11Oct 19Oct 22Oct 27Oct 30Nov 4

Key dataNov 4, 2026

Open$19.37

From 52W high−32.53%

Volume53397.00

Market cap$871.00M

P/E (TTM)—

P/S (TTM)0.1x

Div yield—

Key dataNov 4, 2026

Open

$19.37

From 52W high

−32.53%

Volume

53397.00

Market cap

$871.00M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

1.5x

P/E (TTM)

—

RSI (14)

25.2

MomentumView details →

1D Return

−9.35%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

1.5x

EV/Sales

0.9x

P/S (TTM)

0.1x

P/B (TTM)

0.1x

ProfitabilityView details →

Gross Margin

66.02%

Net Margin

27.66%

EBITDA Margin

55.20%

ROE (TTM)

17.74%

ROA (TTM)

9.24%

Asset Turnover

0.33x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

−2.90%

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

−9.35%

YTD Return

—

1Y Return

—

RSI (14)

25.2

vs 50D SMA

−17.84%

vs 200D SMA

−15.23%

Capital & dividendView details →

Debt/Equity

0.46x

Current Ratio

0.44x

Quick Ratio

0.44x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

6.49B

Net Income (TTM)

1.80B

Op. CF (TTM)

3.31B

Latest newsMore news →

No recent news for CTY.

Similar companies

Monte Rosa Therapeutics, Inc.GLUE Pharming Group N.V.PHAR Theravance Biopharma, Inc.TBPH Alto Neuroscience, Inc.ANRO Prime Medicine, Inc.PRME MeiraGTx Holdings plcMGTX Find similar companies →

Latest newsMore news →

No recent news for CTY.